English
Bamlanivimab Biosimilar - Research Grade
Bamlanivimab Biosimilar - Research Grade, Human IgG1(K214R)-Kappa
Artikelnummer
ICH5180-20MG
Verpackungseinheit
20mg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: SARS-CoV-2.
Specificity: Detects SARS-CoV-2.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Bamlanivimab.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Specificity: Detects SARS-CoV-2.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Bamlanivimab.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
